Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Chinese Academy of Medical Sciences & Peking Union Medical College

Status: Enrolling

Conditions: Triple Negative Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04145947

PUMCH-BC502

Details and patient eligibility

About

The relationship between immune inflammation-related protein complexes in blood of triple negative breast cancer patients and recurrence or metastasis of breast cancer will be studied.

Full description

200 patients with triple negative breast cancer will be followed up. Peripheral venous blood was collected every 3 to 6 months. Change regularity of breast cancer-specific immune inflammation-related protein complexes in blood at different follow-up time points will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.

Enrollment: 200 estimated patients

Sex: Female

Ages: 36 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female
• Postoperative pathology confirmed invasive breast cancer after surgery for breast lump
• Breast cancer-related chemotherapy and radiotherapy completed
• triple negative breast cancer patients
• age ≤ 60 years old

Exclusion criteria

• Male
• Aged above 60
• Breast Carcinoma in situ
• Women in pregnancy or breastfeeding
• Suffering from other malignant tumors
• Non-compliant patient

Trial design

200 participants in 1 patient group

triple negative breast cancer

Description:

triple negative breast cancer patients with age ≤ 60 years old